Dec. 18, 2023
In a recent development for the scientific community, the AIDS and Cancer Specimen Resource (ACSR) has enhanced its ability to …
Receptor.AI has announced ArtiDock, the best-in-class model for “AI docking," which predicts the binding poses of small molecule ligands in protein …
Nov. 27, 2023
In recent news, Recursion (NASDAQ: RXRX), a prominent clinical stage TechBio firm, has announced the signing of agreements to acquire …
Nov. 17, 2023
Companies are increasingly turning to generative artificial intelligence (AI) to develop new therapeutics, giving biotech companies with patents on these …
Nov. 7, 2023
In the ongoing pursuit of new drugs and medical treatments, the pharmaceutical sector faces a complex task: verifying the safety …
Nov. 7, 2023
The digital transformation of biopharmaceutical manufacturing has continued at a rapid pace as companies mine the rich sources of data …
Nov. 3, 2018
The first biologics drug, humanized insulin (5.8 kDa), became available in 1982 following the advent of biotechnology, and it marked …
Oct. 29, 2023
As the potential of artificial intelligence (AI) continues to unfold, how is it revolutionizing the intricate landscape of clinical trials? …
Oct. 20, 2023
It is hard to overestimate the potential of biotechnology to address some of the most pressing challenges of the 21st …
Oct. 20, 2023
‘Garbage in, garbage out’ is a well-known principle in the machine learning (ML) community, and it is certainly true when …
Oct. 6, 2023
From gene editing and artificial intelligence (AI)-driven protein design, to cutting-edge 3D bioprinting, tissue engineering and microfluidics – Lithuania appears …
Sept. 22, 2023
In the dynamic field of life sciences, both biological research and AI are coming together to alter our perspective on …
